Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Positive plasma cotinine during platinum-based chemotherapy is associated with poor response rate in advanced non-small cell lung cancer patients.
Dacosta-Noble P, Costantini A, Dumenil C, Dumoulin J, Helly de Tauriers P, Giraud V, Labrune S, Emile JF, Alvarez JC, Chinet T, Giroux Leprieur E. Dacosta-Noble P, et al. Among authors: dumenil c. PLoS One. 2019 Jul 1;14(7):e0219080. doi: 10.1371/journal.pone.0219080. eCollection 2019. PLoS One. 2019. PMID: 31260495 Free PMC article.
Plasma Biomarkers Screening by Multiplex ELISA Assay in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.
Costantini A, Takam Kamga P, Julie C, Corjon A, Dumenil C, Dumoulin J, Ouaknine J, Giraud V, Chinet T, Rottman M, Emile JF, Giroux Leprieur E. Costantini A, et al. Among authors: dumenil c. Cancers (Basel). 2020 Dec 31;13(1):97. doi: 10.3390/cancers13010097. Cancers (Basel). 2020. PMID: 33396187 Free PMC article.
Gene expression profile of high PD-L1 non-small cell lung cancers refractory to pembrolizumab.
Talb J, Takam Kamga P, Mayenga M, Costantini A, Julié C, Dumenil C, Dumoulin J, Ouaknine J, Giraud V, Dujon C, Azarian R, Glaser C, Emile JF, Giroux Leprieur E. Talb J, et al. Among authors: dumenil c. Cancer Immunol Immunother. 2022 Nov;71(11):2791-2799. doi: 10.1007/s00262-022-03206-4. Epub 2022 Apr 18. Cancer Immunol Immunother. 2022. PMID: 35435450 Free PMC article.
Circulating tumor DNA evaluated by Next-Generation Sequencing is predictive of tumor response and prolonged clinical benefit with nivolumab in advanced non-small cell lung cancer.
Giroux Leprieur E, Herbretau G, Dumenil C, Julie C, Giraud V, Labrune S, Dumoulin J, Tisserand J, Emile JF, Blons H, Chinet T. Giroux Leprieur E, et al. Among authors: dumenil c. Oncoimmunology. 2018 Jan 29;7(5):e1424675. doi: 10.1080/2162402X.2018.1424675. eCollection 2018. Oncoimmunology. 2018. PMID: 29721388 Free PMC article.
28 results